Showing results (711-720 of 1,191) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|May 23, 2022
Statistical methodology for highly variable compounds: A novel design approach for the ofatumumab Phase 2 bioequivalence studyByron Jones, Bingbing Li, Morten Bagger, et al.Pharmaceutical Statistics|January 11, 2021
A weighted log-rank test and associated effect estimator for cancer trials with delayed treatment effectChang Yu, Xiang Huang, Hui Nian, et al.Pharmaceutical Statistics|March 3, 2020
Combination of several matching adjusted indirect comparisons (MAICs) with an application in psoriasisDaniel Saure, Alexander Schacht, Zbigniew Kadziola, et al.Pharmaceutical Statistics|April 29, 2023
Improved inference for MCP-Mod approach using time-to-event endpoints with small sample sizesMárcio A Diniz, Diego I Gallardo, Tiago M MagalhãesPharmaceutical Statistics|July 30, 2020
MMRM vs joint modeling of longitudinal responses and time to study drug discontinuation in clinical trials using a "de jure" estimandAlberto García-Hernandez, Teresa Pérez, María Del Carmen Pardo, et al.Pharmaceutical Statistics|July 15, 2020
Optimal decision-making in oncology development programs based on probability of success for phase III utilizing phase II/III data on response and overall survivalHeiko Götte, Junyuan Xiong, Marietta Kirchner, et al.Pharmaceutical Statistics|August 22, 2020
Evaluation of alternative confidence intervals to address non-inferiority through the stratified difference between proportionsJiatong Sui, Jenny Jiao, Yijun Sun, et al.Pharmaceutical Statistics|April 8, 2015
Single-arm phase II trial design under parametric cure modelsJianrong WuPharmaceutical Statistics|April 15, 2021
A semiparametric modeling approach for analyzing clinical biomarkers restricted to limits of detectionSandipan Dutta, Susan HalabiPageof 120